
### [NCIT:C80280](http://purl.obolibrary.org/obo/NCIT_C80280)
**Label:** Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

**Subclasses:** [NCIT:C8926](http://purl.obolibrary.org/obo/NCIT_C8926) (Recurrent Centroblastic Lymphoma), [NCIT:C8927](http://purl.obolibrary.org/obo/NCIT_C8927) (Refractory Centroblastic Lymphoma), [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C8931](http://purl.obolibrary.org/obo/NCIT_C8931) (Stage IV Centroblastic Lymphoma), [NCIT:C45231](http://purl.obolibrary.org/obo/NCIT_C45231) (Diffuse Large B-Cell Lymphoma Unclassifiable), [NCIT:C8137](http://purl.obolibrary.org/obo/NCIT_C8137) (Stage III Adult Immunoblastic Lymphoma), [NCIT:C8930](http://purl.obolibrary.org/obo/NCIT_C8930) (Stage III Centroblastic Lymphoma), [NCIT:C8124](http://purl.obolibrary.org/obo/NCIT_C8124) (Stage II Adult Immunoblastic Lymphoma), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7873](http://purl.obolibrary.org/obo/NCIT_C7873) (Adult Immunoblastic Lymphoma), [NCIT:C7263](http://purl.obolibrary.org/obo/NCIT_C7263) (Thyroid Gland Immunoblastic Lymphoma), [NCIT:C8078](http://purl.obolibrary.org/obo/NCIT_C8078) (Stage I Adult Immunoblastic Lymphoma), [NCIT:C9079](http://purl.obolibrary.org/obo/NCIT_C9079) (Childhood Immunoblastic Lymphoma), [NCIT:C36081](http://purl.obolibrary.org/obo/NCIT_C36081) (Diffuse Large B-Cell Lymphoma Activated B-Cell Type), [NCIT:C3461](http://purl.obolibrary.org/obo/NCIT_C3461) (Immunoblastic Lymphoma), [NCIT:C4074](http://purl.obolibrary.org/obo/NCIT_C4074) (Centroblastic Lymphoma), [NCIT:C36080](http://purl.obolibrary.org/obo/NCIT_C36080) (Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type), [NCIT:C8163](http://purl.obolibrary.org/obo/NCIT_C8163) (Recurrent Adult Immunoblastic Lymphoma), [NCIT:C45219](http://purl.obolibrary.org/obo/NCIT_C45219) (Diffuse Large B-Cell Lymphoma by Gene Expression Profile), [NCIT:C8150](http://purl.obolibrary.org/obo/NCIT_C8150) (Stage IV Adult Immunoblastic Lymphoma), [NCIT:C6916](http://purl.obolibrary.org/obo/NCIT_C6916) (Anaplastic Lymphoma), [NCIT:C8928](http://purl.obolibrary.org/obo/NCIT_C8928) (Stage I Centroblastic Lymphoma), [NCIT:C8929](http://purl.obolibrary.org/obo/NCIT_C8929) (Stage II Centroblastic Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C38329](http://purl.obolibrary.org/obo/NCIT_C38329) (Thymic B-Lymphocyte) 58.33%
- [NCIT:C37011](http://purl.obolibrary.org/obo/NCIT_C37011) (Plasmablastic Immunoblast) 58.33%
- Thing 51.59%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36273](http://purl.obolibrary.org/obo/NCIT_C36273) (Small Lymphocytic Lymphoma with Plasmacytoid Differentiation))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36272](http://purl.obolibrary.org/obo/NCIT_C36272) (Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36271](http://purl.obolibrary.org/obo/NCIT_C36271) (T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36270](http://purl.obolibrary.org/obo/NCIT_C36270) (T-Cell Prolymphocytic Leukemia, Small Cell Variant))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36261](http://purl.obolibrary.org/obo/NCIT_C36261) (Non-Hereditary Clear Cell Renal Cell Carcinoma))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36260](http://purl.obolibrary.org/obo/NCIT_C36260) (Hereditary Clear Cell Renal Cell Carcinoma))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36258](http://purl.obolibrary.org/obo/NCIT_C36258) (Lymphatic Spread))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36253](http://purl.obolibrary.org/obo/NCIT_C36253) (Bone Marrow Basophilia))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36252](http://purl.obolibrary.org/obo/NCIT_C36252) (Ineffective Hematopoiesis))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36250](http://purl.obolibrary.org/obo/NCIT_C36250) (Auer Rods Present))) 43.69%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C36246](http://purl.obolibrary.org/obo/NCIT_C36246) (Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells))) 43.69%


